Herbal options can be woven into evidence-based care when safety and interactions are considered. Western data suggest chaste tree may modestly reduce global PMS scores and mastalgia—potentially fitting individuals with breast tenderness, irritability, or cyclic prolactin sensitivity. St. John’s wort may help mood-dominant PMS but can interact with SSRIs, oral contraceptives, anticoagulants, and many other drugs via CYP3A4 and P-glycoprotein induction; concurrent use with serotonergic medications increases the risk of serotonin toxicity and requires clinician oversight. Evening primrose oil has not shown consistent benefit for PMS or mastalgia in rigorous trials; discussion with a clinician may help set expectations. Magnesium may help with fluid retention, headaches, and mood tension; formulation and gastrointestinal tolerance vary, and caution is warranted in kidney disease and with drugs whose absorption it can impair.
From the Eastern side, formula-based approaches such as Xiao Yao San/Jia Wei Xiao Yao San (TCM) or Kamishoyosan (Kampo) target mixed mood and somatic symptoms; preliminary trials and centuries of use support consideration when guided by a trained practitioner. Proposed mechanisms include modulation of the hypothalamic–pituitary–adrenal axis, GABAergic tone, and smooth muscle contractility (e.g., paeoniflorin from Bai Shao; ferulic acid from Dang Gui). Ayurvedic strategies such as Shatavari- or Ashoka-containing formulations are traditionally used for cycle regularity and mood, with limited contemporary clinical trials; individualized plans often pair herbs with abhyanga, diet, and breath practices.
Potential conflicts include: herb–drug interactions (notably St. John’s wort with SSRIs, oral contraceptives, transplant or anticoagulant drugs); dopaminergic effects of chaste tree that may interact with antipsychotics or dopamine agonists; bleeding risk with coumarins/antiplatelets when combining Dang Gui, Bai Shao, or high-dose fish oils; electrolyte effects of licorice-containing formulas (elevated blood pressure and low potassium); and magnesium impairing absorption of levothyroxine or certain antibiotics when taken close together. Pregnancy and breastfeeding are special contexts: many PMS-directed herbs (e.g., chaste tree, St. John’s wort, concentrated TCM formulas) are generally avoided unless a clinician advises otherwise. Quality matters: look for products tested for identity, contaminants, and active markers (e.g., casticin in chaste tree; hypericin/hyperforin in St. John’s wort; GLA percentage in evening primrose oil). Kampo extracts in Japan are standardized; quality of TCM/Ayurvedic products varies by manufacturer and region.
Practical integration often involves: confirming the PMS/PMDD diagnosis with prospective charting; aligning on priorities (mood vs pain vs bloating); selecting one change at a time; and monitoring for at least two cycles. Western clinicians may prioritize SSRIs or oral contraceptives for moderate-to-severe cases, while collaborating with TCM/Kampo or Ayurvedic practitioners when patients prefer herbal-first or combined strategies. Research gaps include high-quality, placebo-controlled trials for classical formulas, head-to-head comparisons with standard therapies, and better safety/interaction mapping. Consult your healthcare provider before making changes to your health regimen.